Comparison of Sevoflurane and Desflurane with Dexmedetomidine for Recovery in Neurosurgical Patients Undergoing Supratentorial Tumor Surgery
Annals of African Medicine · 2026
DOI: 10.4103/aam.aam_314_25 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Annals of African Medicine, 2026. Verfasst von Muthyala Pavankumar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India. Hauptthemen laut MEDLINE: Dexmedetomidine, Sevoflurane, Desflurane, Supratentorial Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Anesthetic management in neurosurgical procedures requires rapid recovery and stable hemodynamics to enable early neurological evaluation. Sevoflurane and desflurane, with low blood–gas solubility, are commonly used inhalational agents. Dexmedetomidine, an α2-adrenergic agonist, provides sedation and hemodynamic stability. Limited studies have compared sevoflurane and desflurane in combination with dexmedetomidine for neurosurgical recovery. Aims and Objectives: To compare the recovery profile, cognitive function, and intraoperative brain relaxation in patients undergoing supratentorial tumor surgery under sevoflurane–dexmedetomidine versus desflurane–dexmedetomidine anesthesia. Materials and Methods: This prospective observational study was conducted at Kasturba Medical College, Mangalore, between March 2023 and August 2024. Ninety-six patients aged 40–65 years undergoing elective supratentorial craniotomy were enrolled and divided into two groups: Group A (sevoflurane with dexmedetomidine) and Group B (desflurane with dexmedetomidine). Recovery times (emergence, extubation, orientation), cognitive function (Short Orientation Memory Concentration Test, SOMCT), brain relaxation score, hemodynamics, and adverse events were assessed. Data were analyzed using independent t-tests and Chi-square tests, with P < 0.05 considered significant.
Results
Desflurane group showed significantly shorter emergence (8.1 ± 1.4 vs. 12.9 ± 1.2 min), extubation (13.9 ± 2.8 vs. 18.8 ± 1.3 min), and orientation times (36.2 ± 4.8 vs. 41.6 ± 4.3 min) compared to sevoflurane (P < 0.001). Cognitive recovery was faster with desflurane (SOMCT 7.8 ± 1.6 vs. 13.2 ± 3.0; P < 0.001). Brain relaxation was superior in the desflurane group (P < 0.001). Adverse events were fewer with desflurane (4.2% vs. 20.8%; P = 0.01). Hemodynamics remained stable in both groups.
Conclusion
Desflurane with dexmedetomidine provides faster emergence, better cognitive recovery, superior brain relaxation, and fewer adverse events compared to sevoflurane in supratentorial neurosurgery. It may be preferred when rapid postoperative neurological assessment is required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, Kasturba Medical College Mangalore, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Zitieren
APA
Pavankumar, M., Sunil, B. V., & Bhat, S. (2026). Comparison of Sevoflurane and Desflurane with Dexmedetomidine for Recovery in Neurosurgical Patients Undergoing Supratentorial Tumor Surgery. Annals of African Medicine. https://doi.org/10.4103/aam.aam_314_25
Vancouver
Pavankumar M, Sunil BV, Bhat S. Comparison of Sevoflurane and Desflurane with Dexmedetomidine for Recovery in Neurosurgical Patients Undergoing Supratentorial Tumor Surgery. Annals of African Medicine. 2026. doi:10.4103/aam.aam_314_25
BibTeX
@article{Pavankumar2026,
author = {Pavankumar, Muthyala and Sunil, B V and Bhat, Sonal},
title = {Comparison of Sevoflurane and Desflurane with Dexmedetomidine for Recovery in Neurosurgical Patients Undergoing Supratentorial Tumor Surgery},
journal = {Annals of African Medicine},
year = {2026},
doi = {10.4103/aam.aam_314_25}
}
EUVIMED